Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF)
David J Whellan,Christopher M O'Connor,Kevin T Ousdigian,Te-Hsin Lung,PARTNERS HF Study Investigators,E Martin Kloosterman,Mark Donahue,Arnold J Greenspon,Andrew L Smith,Saleem Ahmad,Sri Teegala,Sana Al-Khatib,Vivian West,Thabet Alsheikh,Bridget Lane,Aysha Arshad,Kathleen Sayles,Walter Atiga,Deanna Overbeck,Dorothy Banish,Vicky Nicely,Joseph Bissett,Sharon Shuler,Reginald Blaber,Kathy Enochs,Gabriel Breuer,Pamela Terry,Sheldon Brownstein,Adriane Hausfeld,Jeffrey Buetikofer,Monica Chase,Scott Burkett,Carol Powell,Lon Castle,Cynthia Kovach,A Bleakley Chandler,Paula Easler,Rajiv Chandra,Terry Murphy,Michael Chaskes,Deborah Evert,James Cockrell,Melissa Dillon,Harry Colfer,Peggy Ward,George Crossley,Janice Sensing,Joel Cutler,Claire Berg,Dan Dan,Cynthia Steele,Steven Davis,Leann Goodwin,David DeLurgio,Paige Smith,Westby Fisher,Claudia Focks,Malcolm Foster 3rd,Lindsay Howell,Robert Gatewood,Lois Banks,Carolyn Goren,Sue Anderson,Venk Gottipaty,Monica Sanders,Eric Grubman,Nancy Hinchion,Madhukar Gupta,Ersela McGary,Alain Heroux,Melissa Hill,Bengt Herweg,Beth Major,Michael Hess,Kim Hall,Mark Hiser,Judy Nagel,Jonathan Hobson,Beth Schelle,James Hochrein,Sally Milks,Doug Hodgkin,Ann Antolick,John Holmes,Sara Hollowell,Andrew Hordes,Karen Hayden,Patrick Hranitzky,Sara Hoffman,Kevin Hsu,Sonja Hart,Steven Hutchins,Paula Cunningham,Alberto Interian Jr,Carlos Arrietta,Brian Jaffe,Lori Conrad,Mohammed-Reza Jazayeri,Barb Loomis,Charles Joyner,Sallie Amaral,Stephen Keim,Mary Zook,Charles Kinder,Elaine Enger,Jeffrey Kusher,Elizabeth Saar,Steven Kutalek,Christina Baessler,David Langholz,Barb Dobbs,Daniel Levine,Nancy Kelly,David Lin,Anthony Killian,Keith Lurie,Laura VanHeel,Daniel Lustgarten,Kristin Gilbert,Anastasios Manaris,Maryann DeFalco,David Mann,Debra Mudd,David Martin,Nancy Flowers,Riyad Mohama,Patty Eisenbraun,George Monir,Stephen Moore,Darlene Carr,James Mullin,Cheryl Ogden,Jaime Murillo,Linette Klevan,Allen Naftilan,Judy Francescon,David Navratil,Nancy Newell,Syed Nayyar-Shah,Bonnie Stagner,Allan Nichols,Ryan Bailey,John Norris,Julie Davis,Ahmed Osman,Shanita Isaac,Manuel Otero-Cagide,Jolene Ehlert,James O'Toole,Maxine Hovis,Eugen Palma,Patricia Flynn,Behzad Pavri,Christine Powel,Charles Porter,Caroline Murray,Russell Reeves,Brandon Williams,Rizo Rizo-Patron,Karen Belco,David Rodak,Darla Howard,Derek Rodrigues,Michelle Allen,Carlos Roman,Anmarie Pfeifer,Murray Rosenbaum,Michelle Olitzky,Sean Russell,Rebecca LeFavor,Matthew Sackett,Joyce White,Lisa Schiller,Nichole Elmore,Lyle Siddoway,Barb Delio-Cox,Marc Silver,Joni Stallings,Amarnauth Singh,Deborah Beasley,J Thomas Svinarich,Karen Moore,Thomas Swain,Lisa Parker,Venkatakrishna Tholakanahalli,Jesus Val-Mejias,Pat Patterson,Kris Vijay,Vicki Comacho,Manish Wadhwa,Catharine Hunt,Martin Wiseman,Jill Kandrac,Raymond Wood Jr,Beth King,Gregg Yamada,Myrna Oberholzer,Sivaraman Yegya-Rama,Sheri Mannino,John Zornosa,Anita Todd
DOI: https://doi.org/10.1016/j.ahj.2008.06.036
Abstract:Background: Heart failure (HF) is a common medical problem with significant morbidity and mortality. Recently, device-based therapy, cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillators (ICDs), and combined CRT and ICD have become established therapies in patients with HF receiving standard medical therapy. Contemporary implantable devices are able to continuously monitor, store, and display long-term diagnostic information. Daily diagnostic information includes intrathoracic impedance, patient activity, hours spent in atrial tachycardia/fibrillation, ventricular rate during atrial tachycardia/fibrillation, ventricular tachyarrhythmia episodes, ICD shocks, day and night heart rate, and heart rate variability. Methods: PARTNERS HF is a prospective, nonrandomized, multicenter observational study. Patient data are collected at baseline and at 3, 6, 9, and 12 months. Our objectives are to assess the relationship between the (1) diagnostic data and HF-related events, (2) diagnostic data and HF-related health care utilizations, and (3) OptiVol (Medtronic, Inc, Minneapolis, MN) fluid monitoring diagnostic data and clinically relevant pulmonary congestion events in a subset of patients. The study has enrolled 1,024 patients with a commercially available combined CRT and ICD system at 100 sites in the United States. Participants will be followed for 1 year. Results: Enrollment was completed in January 2007. Key baseline characteristics include the following: mean age of 68.4+/-10.8 years, 32% female, 13% people of color, 64% with ischemic HF, and >80% of patients reported to be on recommended HF medications at enrollment. Conclusions: The results of PARTNERS HF could help identify device diagnostic information that may provide an early recognition of impending HF-related events.